#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Insulinoma Systemic scleroderma Acquired ATTR amyloidosis Spina bifida Endometrial cancer recurrent Sickle cell anaemia Hyperadrenocorticism Alveolar rhabdomyosarcoma Inclusion body myositis Hodgkin's disease Marginal zone lymphoma refractory Hypoxic-ischaemic encephalopathy Acromegaly Leukocyte adhesion deficiency type I Epilepsy with myoclonic-atonic seizures More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma – Treatment Waldenstrom’s macroglobulinaemia – Life with Disease Fabry’s disease – Diagnostics Gastrointestinal stromal tumour Alagille syndrome – Life with Disease Haemophilia A without inhibitors – Diagnostics Synovial sarcoma metastatic – Diagnostics Myelodysplastic syndrome with excess blasts Hereditary hypophosphataemic rickets – Treatment Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ampicillin Sodium Zinc Acexamate Neratinib Dexamfetamine Sulfate Mk-0482 Peginterferon Beta-1A Tulmimetostat Gilteritinib Dimethyl Fumarate Tecaginlimab Tisotumab Vedotin Meropenem Depemokimab Abc-15A-116 Deferiprone GSKVX000000030918 Follitropin Alfa GSKVX000000034798 Emicizumab Liquid Paraffin More therapies…

    Learn about Your Condition

    Friedreich's ataxia Osteonecrosis of jaw BK virus infection Cardiomyopathy Endotracheal intubation Dengue fever Post procedural swelling Skin candida Acute kidney injury Macular oedema Adenovirus infection Synovial sarcoma metastatic Blood iron increased Stomatitis Tissue anoxia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic kidney disease

  • A study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    • Cardiac failure chronic
    • Chronic kidney disease
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    • Spironolactone
    The Netherlands

  • Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypothyroidism
    • Chronic kidney disease
    Investigated Drugs:
    • Levothyroxine
    Denmark

  • A study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease

    Recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Austria Belgium Bulgaria Czechia Estonia France +10

  • A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic kidney disease
    • Alport’s syndrome
    Czechia France Germany Italy Poland Portugal +1

  • A study testing finerenone compared to placebo in patients with chronic kidney disease who are not taking renin-angiotensin-system inhibitors

    Recruiting

    3 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Spain

  • A study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Empagliflozin
    Belgium France Germany Hungary Italy The Netherlands +4
1 2 3 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!